SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Regulatory science and biotech building at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

18 organizations at SITC 2026 present work in regulatory, policy & biotech building, led by pharma and biotech companies. Between them they bring 28 presentations to the program. Most represented: U.S. Food and Drug Administration, Merck & Co. and Bristol Myers Squibb. As of Nov 2, 2026.

All 661 organizations at SITC 2026 →

Format
Top represented
Showing 1–7 of 18 organizations
OrganizationSITC 2026 Attendance
Government & non-profit
U.S. federal agency that regulates drugs, biologics and medical devices, including cancer immunotherapies.
Session
Wed Nov 4
2:10pm–2:55pm
Session
Wed Nov 4
3:10pm–3:55pm
Panel Discussion 2: Biomarker Discovery and Digital AI
Biomarkers · AI & data
Session
Wed Nov 4
4:10pm–4:55pm
Panel Discussion 3: Regulatory Framework for New IO Agents
Regulatory · New agents
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm
Merck & Co.
Rahway, NJ
Large pharma
Global pharmaceutical company, known as MSD outside the US and Canada, running a broad oncology research and clinical development program.
Booth
Exhibiting at Booth 1228
Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm
Session
Wed Nov 4
3:10pm–3:55pm
Session
Thu Nov 5
12:00pm–1:30pm
Session
Thu Nov 5
6:45pm–7:20pm
Session
Fri Nov 6
3:55pm–5:30pm
Biotech Session: The Next Generation of Off-the-Shelf IO
Cell therapy
  1. 3:55pm–4:10pmTargeting PRAME with IMA402, a Novel Bispecific T-Cell Engager (TCER) - Initial Clinical ResultsImmatics
  2. 4:10pm–4:25pmIn vivo Cell Therapy Platforms for CancerEli Lilly and Company
  3. 4:25pm–4:40pmAllogeneic CAR T: A Platform Built for Patient Access – in Cancer and BeyondAllogene Therapeutics
  4. 4:40pm–4:50pmTargeted LNP Delivery of an RNA Gene Writer Enables In Vivo Generation of Functional CAR-T Cells in Non-human PrimatesTessera Therapeutics
  5. 4:50pm–5:00pmSTEALTH-001: A Phase 1 Study of VET3-TGI, an Oncolytic Vaccinia Virus Encoding TGFb Inhibitor and IL-12, for the Treatment of Advanced Solid TumorsUPMC Hillman Cancer Center
  6. 5:00pm–5:30pmIn Vivo - Ex Vivo DebateKite Pharma, Massachusetts Institute of Technology, Roswell Park Comprehensive Cancer Center, Azalea Therapeutics
Large pharma
Global pharmaceutical company whose immuno-oncology medicines include the checkpoint inhibitors nivolumab and ipilimumab.
Session
Thu Nov 5
6:45pm–7:20pm
Universities & research institutes
A public research university and academic health center in Georgia.
Poster
Sat Nov 7
12–1:30pm
6:40–8:10pm
Biotech
Develops and commercializes tumor-infiltrating lymphocyte (TIL) cell therapies for people with solid tumors.
Booth
Exhibiting at Booth 700
Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm
Session
Wed Nov 4
4:10pm–4:55pm
Amgen
Thousand Oaks, CA
Large pharma
Large biotechnology company whose oncology medicines include the bispecific T-cell engagers blinatumomab and tarlatamab.
Session
Thu Nov 5
12:00pm–1:30pm
Session
Thu Nov 5
7:25pm–8:10pm
Panel: Financing and Partnerships
Regulatory
Biotech
Clinical-stage biotech developing antibodies that target TCR V-beta chains to selectively activate T cell subsets against cancer.
Workshop
Wed Nov 4
2:00pm–5:00pm
Biotech Regulatory Roundtable
  1. 2:00pm–2:10pmOpening Remarks: SITC Biotech Initiative: A Quest for 100 Novel Agents
  2. 2:10pm–2:55pmPanel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics
  3. 2:55pm–3:10pmNetworking Break
  4. 3:10pm–3:55pmPanel Discussion 2: Biomarker Discovery and Digital AI
  5. 3:55pm–4:10pmNetworking Break #2
  6. 4:10pm–4:55pmPanel Discussion 3: Regulatory Framework for New IO Agents
  7. 4:55pm–5:00pmClosing Remarks
Workshop
Wed Nov 4
2:10pm–2:55pm
Workshop
Wed Nov 4
4:10pm–4:55pm
Session
Thu Nov 5
12:00pm–1:30pm
Workshop
Thu Nov 5
5:00pm–9:00pm
Launching Biotech Startups: Funding, Pitching, Partnerships
  1. 5:00pm–5:30pmWelcome Reception
  2. 5:40pm–6:40pmPharma Perspectives on External Innovation
  3. 6:45pm–7:20pmPanel: Pharma Perspectives on External Innovation
  4. 7:25pm–8:10pmPanel: Financing and Partnerships
  5. 8:10pm–9:00pmClosing Networking Reception

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in regulatory, policy & biotech building

Tell us what you sell and we’ll find the people at organizations working on regulatory, policy & biotech building most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SITC 2026 by

Exhibit hall

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction